drugset / Trial / NCT02643719

Migraine Treatment in ED

NCT02643719

Withdrawn NYU Langone Health
RandomizedParallel-groupDouble-blindTreatment

Summary

Randomized pilot feasibility study evaluating the impact of introducing behavioral treatment for migraine in the Emergency Department (ED) and prescribing migraine preventive medications in the ED. The study will examine the effect of these treatments, both individually and in combination, on pain severity and headache-related disability. This study is designed to examine the feasibility of comparing four interventions for ED patients presenting with migraine. Group 1: Starting topiramate; Group 2: Doing a brief behavioral intervention; Group 3: Treating with combination therapy of topiramate and behavioral intervention; and Group 4: Standard of Care.

Timeline

Start
2015-12
Primary completion
2017-10
Completion
2017-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Topiramate Small molecule 100 mg
Comparator Naproxen Small molecule 500 mg
Comparator Sumatriptan Unknown 100 mg

Indications